Pharmacy Scholarship: Kam Nola

Curtis JR, Weinblatt M, Saag K, Bykerk VP, Furst DE, Fiore S, St John G, Kimura T, Zheng S, Bingham CO III, Wright G, Bergman M, Nola K, Charles-Schoeman C, Shadick N. Data-driven patient clustering and differential clinical outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study (BRASS) Registry. Arthritis Care Res (Hoboken). 2020;doi:10.1002/acr.24471

Curtis JR, Weinblatt ME, Saag K, Bykerk V, Charles-Schoeman C, Fiore S, John GS, Kimura T, Zheng S, Bingham C, Wright G, Bergman M, Nola KM, Furst DE, Shadick N. Exploring heterogeneity in rheumatoid arthritis: Patient profiling through principal component and cluster analysis of the BRASS registry. Ann Rheum Dis. 2019;78(Suppl 2):135. doi: 10.1136/annrheumdis-2019-eular.541

Punekar R, Choi J, Boklage S, Iglesias-Rodriguez M, Nola K. Real-world dose modification patterns of subcutaneous tocilizumab among patients with rheumatoid arthritis. Am Health Drug Benefits. 2019;12(8):400-409.

Zuckerman A, James C, Choi J, Peter M, Nadler M, Nola KM, Jones A, Cooper K, DeClercq J, Choi L, Tanner S. Switching and cycling among patients with rheumatoid arthritis at an integrated health system specialty pharmacy. Journal of Managed Care & Specialty Pharmacy. 2019;25(10-a Suppl):S81. doi: 10.18553/jmcp.2019.25.10-a.s1

Nola KM. Disaster preparedness in rheumatology: Are you ready? Paper presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting; October 19-24, 2018; Chicago, IL.

Nola KM, Ferris LK. How are novel therapies raising the bar for psoriasis treatment? Pharmacy Continuing Education Program, PRIME Education, LLC; October 2018.

Pinelli NR, Sease JM, Nola KM, Kyle JA, Heldenbrand SD, Penzak SR, Ginsburg DB. The importance of authentic leadership to all generations represented within academic pharmacy. Am J Pharm Educ. 2018;82(6):6694. doi: 10.5688/ajpe6694

Nola KM. Pharma update: Latest prescribing information for adults. Paper presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting; October 19-24, 2018; Chicago, IL.

Bridges SL, Jr., White DW, Worthing AB, Gravallese EM, O'Dell JR, Nola KM, Kay J, Cohen SB. The science behind biosimilars: Entering a new era of biologic therapy. Arthritis Rheumatol. 2018;70(3):334-344. doi: 10.1002/art.40388

Miller LN, Lee JT, Nola KM, Morley S, Campbell TM, Davis RL. Assessing student pharmacist self-awareness throughout the co-curriculum: Engaging faculty mentors as key evaluators. Am J Pharm Educ. 2017;81(5). doi: 10.5688/ajpe815S6

Nola KM. Biosimilars and community pharmacy: What you need to know. Pharmacy Continuing Education Program, Smith Drug Company Annual Meeting; 2017.

McClain R, Nola KM, Pouliot JD, Blackburn H, Bennett A. Effectiveness of pharmacist intervention on initiating statin therapy in diabetes patients. Poster presented at: Pharmacy Quality Alliance Annual Meeting; 2017; Baltimore, MD.

Nola KM, Rigby WFC. Navigating the new territory of biosimilars: Case studies in inflammatory diseases. Pharmacy Continuing Education Program, PRIME Education, LLC; December 2017.

English S, Clauson KA, Nola KM, Breeden EA, Stepnowsky C, Adur A, Drobnich D, Lee JT. A pharmacist-led effort to leverage digital health to screen for sleep disorders and identify the impact of medications on sleep. Poster presented at: Tennessee Society of Health-System Pharmacists Midyear Seminar; February 2017; Nashville, TN.

Nola KM. Pharma update: Safety, new indications, latest approvals. Paper presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting; November 3-8, 2017; San Diego, CA.

Nola KM. An update on biosimilars: What you need to know. Paper presented at: Tennessee Pharmacists Association Summer Meeting; July 7-9, 2017; Kingsport, TN.

Nola KM, Genovese M. Daybreak discussions: On new guidelines and evidence that are changing rheumatoid arthritis management. Pharmacy Continuing Education Program, PRIME Education, LLC; 2016.

Nola KM, Genovese M. Daybreak discussions: On new guidelines and evidence that are changing rheumatoid arthritis management. Paper presented at: Academy of Managed Care Pharmacy Managed Care & Specialty Pharmacy Annual Meeting; April 19-22, 2016; San Francisco, CA.

Nola KM, Genovese M. The influence of guidelines on new therapeutic mechanisms in RA & what it means for managed care. Pharmacy Continuing Education Program, PRIME Education, LLC; 2016.

Yazdany J, Myslinski R, Miller A, Francisco M, Desai S, Schmajuk G, Lacaille D, Barber CE, Orozco C, Bunyard M, Bergman MJ, Passo M, Matteson EL, Olson R, Silverman S, Warren R, Nola KM, Robbins M.. Methods for developing the American College of Rheumatology's electronic clinical quality measures. Arthritis Care Res (Hoboken). 2016;68(10):1402-1409. doi: 10.1002/acr.22985

St. Clair W, Nola KM. Volunteers essential to future of ACR & AHRP. The Rheumatologist. 2015.

Nola KM. Development and implementation of an elective course titled “Pharmacy Management of Vulnerable and Underserved Populations”. Am J Pharm Educ. 2014;78(5). doi: 10.5688/ajpe785111

Flood J, Nola KM. Update on health care reform in 2014 under the Affordable Care Act. The Rheumatologist. 2014.

Nola KM. Women’s health: Update on rheumatologic care. Paper presented at: Tennessee Pharmacists Association Annual Convention; July 21-24, 2014; HIlton Head, SC.

Nola KM. Change of seasons. TPA Newstream. 2013.

Nola KM. The development dissemination, and interpretation of a survey regarding the expanding roles of pharmacy technicians in future pharmacy practice. J Am Pharm Assoc. 2013;53(2):e111-112. doi: 10.1331/JAPhA.2013.13508

Falconer D, Nola KM. Lung cancer care in a community hospital cancer center. Paper presented at: Tennessee Pharmacists Association Annual Convention; July 15-18, 2013; Chattanooga, TN.

Falconer D, Nola KM. Metastatic colorectal cancer care in Florida. Paper presented at: Tennessee Pharmacists Association Annual Convention; July 15-18, 2013; Chattanooga, TN.

Nola KM. The role of the pharmacist in the interdisciplinary rheumatology team. Paper presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting; October 25-30, 2013; San Diego, CA.

Nola KM. The year in review. TPA Newstream. 2013.

Nola KM. Exciting developments are in the works. TPA Newstream. 2012.

Ruderman EM, Nola KM, Ferrell S, Sapir T, Cameron DR. Incorporating the treat-to-target concept in rheumatoid arthritis. J Manag Care Pharm. 2012;18(9):1-18. doi: 10.18553/jmcp.2012.18.S9-A.1

Nola KM. The medication connection to falls in elderly rheumatic patients. Paper presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting; November 9–14, 2012; Washington, D.C.

Nola KM. New medication developments in rheumatology. Paper presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting; November 9–14, 2012; Washington, D.C.

Nola KM. Pharmacologic management of rheumatologic pain: A mechanistic approach. Paper presented at: American College of Rheumatology State-of-the-Art Symposium; April 28-29, 2012; Chicago, IL.

Nola KM. What’s new in TPA membership? TPA Newstream. 2012.

Nola KM. Continuous quality improvement: Safety, quality, & accountability. Paper presented at: Tennessee Pharmacists Association Annual Convention; 2011; Kingsport, TN.

Nola KM, Black B, Cost MJ. Effectiveness of a pharmacist-based patient-centered medication adherence service. J Am Pharm Assoc. 2011;51(2):214-215. doi: 10.1331/JAPhA.2011.11517

Thompson JR, Nola KM, Rowell C, Marcrom R. Evaluation of teaching methodologies for introduction to pharmacy practice management. Am J Pharm Educ. 2011;75(5):120. doi: 10.5688/ajpe755105

Nola KM. Pharmaceutical advances in treatments of rheumatic disease. Paper presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting; November 4-9, 2011; Chicago, IL.

Nola KM. Pharmacologic management of rheumatologic pain: A mechanistic approach. Paper presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting; November 4-9, 2011; Chicago, IL.

Dlugosz CK, Nola KM. Building the bridge to partnership: Fostering the community and managed care pharmacy relationship. Pharmacy Today. 2010:80-91.

Ayes KB, Nola KM. Cross collaboration using one assignment to meet educational objectives in more than one course. Am J Pharm Educ. 2010;74(5):113. doi: 10.5688/aj740596

Nell K, Black B, Cost MJ, Nola KM. Development of a medication therapy management provider network coordinated through a state pharmacists association. J Am Pharm Assoc. 2010;50(2):225. doi: 10.1331/JAPhA.2010.10511

Nola KM. From managed care to medicare: Understanding reimbursement. Paper presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting; November 6-11, 2010; Atlanta, GA.

Cost MJ, Nola KM, Thompson JR. Pharmacist knowledge and involvement in colorectal cancer screening. J Am Pharm Assoc. 2010;50(2):284. doi: 10.1331/JAPhA.2010.10511

Nola KM, Iversen MD. Rehabilitation in the age of biologics: Medication and physical therapy considerations. Paper presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting; November 6-11, 2010; Atlanta, GA.

Wang J, Thomas J, Byrd D, Nola KM, Liu J. Status of diabetes care among community pharmacy patients with diabetes: analysis of the Medical Expenditure Panel Survey. J Am Pharm Assoc. 2010;50(4):478-484. doi: 10.1331/JAPhA.2010.08173

Cost MJ, Nola KM, Black B. Effect of community pharmacists’ interventions in hypertensive patient management. J Am Pharm Assoc. 2009;49(2):245. doi: 10.1331/JAPhA.2009.09512

Nola KM. Reforming the U.S. Health care system-what does it mean for pharmacy practice. Paper presented at: Tennessee Pharmacists Association/UT Symposium; 2009.

Nola KM. The technician’s role in promoting pharmacy clinical services. Paper presented at: American Association of Pharmacy Technicians National Convention; 2009; Nashville, TN.

Nola KM, Ezell J, Smith E. Development of a universal medication list for Tennessee. J Am Pharm Assoc. 2008;48(2):238. doi: 10.1331/JAPhA.2008.08512

Rowell C, Nola KM, Black B. Identification of medication therapy management services, barriers, and best practices in the state of Tennessee. J Am Pharm Assoc. 2008;48(2):260. doi: 10.1331/JAPhA.2008.08512

Nola KM. Smoking cessation: Workplace education. Presented at: Nike; 2008; Memphis, TN.

Nola KM. Smoking cessation: Workplace education. Presented at: Verizon; 2008; Murfreesboro, TN.